November 20, 2014
Why Are Some Generic Drugs Skyrocketing In Price?
2014-11-20T13:00:00-05:00 https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJkZWZhdWx0c1wvQ2FwaXRvbF9kZWZhdWx0LWltYWdlLmpwZyIsImVkaXRzIjp7InJlc2l6ZSI6eyJmaXQiOiJjb3ZlciIsImhlaWdodCI6NTA2fX19
This video was obtained from the Congressional Committee's website and may be encoded at a different quality than C‑SPAN uses for hearings covered with its own cameras. Also, the video might not start at the beginning of the hearing and much of the data normally added to C‑SPAN.org for committee hearings may not be available.
Report Video Issue
*This text was compiled from uncorrected Closed Captioning.
Related Video
January 28, 2016
Generic Drug Approval Process and Accessibility
Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the…
July 23, 2013
Patent Settlements for Generic Drugs
Witnesses testified on drug company “pay-for-delay” deals, a ploy by to keep generic alternatives off the market. The…
September 21, 2016
Generic Drug Marketplace
Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also…
May 15, 2012
Costs of HIV/AIDS Medicines
Witnesses testified on the cost of HIV/AIDS medications and monopolies created in the HIV/AIDS drugs market. The focus…